Atea Pharmaceuticals (AVIR) Other Gross PP&E Adjustments (2020 - 2022)
Historic Other Gross PP&E Adjustments for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to -$2.5 million.
- Atea Pharmaceuticals' Other Gross PP&E Adjustments fell 101277.53% to -$2.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was -$2.5 million, marking a year-over-year decrease of 101277.53%. This contributed to the annual value of -$5.6 million for FY2021, which is 53004.48% down from last year.
- According to the latest figures from Q3 2022, Atea Pharmaceuticals' Other Gross PP&E Adjustments is -$2.5 million, which was down 101277.53% from -$2.7 million recorded in Q2 2022.
- Atea Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $175000.0 during Q3 2020, with a 5-year trough of -$5.6 million in Q4 2021.
- For the 3-year period, Atea Pharmaceuticals' Other Gross PP&E Adjustments averaged around -$1.7 million, with its median value being -$892000.0 (2020).
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first plummeted by 22971.43% in 2021, then plummeted by 101277.53% in 2022.
- Atea Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$892000.0 in 2020, then plummeted by 530.04% to -$5.6 million in 2021, then soared by 55.05% to -$2.5 million in 2022.
- Its last three reported values are -$2.5 million in Q3 2022, -$2.7 million for Q2 2022, and -$2.9 million during Q1 2022.